COVAX fails to deliver—what went wrong, and can the scheme get back on track?
GENEVA, Switzerland: The COVID-19 Vaccines Global Access (COVAX) initiative provided a glimmer of hope during the first months of the pandemic. For many health workers in low-income countries, that hope has been eclipsed by logistical, material and bureaucratic problems. COVAX missed its target of providing two billion vaccine doses in 2021 but hopes that the milestone can be reached in the first quarter of 2022.
Did you miss our previous article…